OptimizeRx Corporation
NCM: OPRX📈 ZcoreAI Score
Our AI model analyzes OptimizeRx Corporation's price action across multiple timeframes using regression channels and statistical scoring.
Get OPRX Z-Score →About OptimizeRx Corporation
📊 Fundamental Analysis
OptimizeRx Corporation demonstrates a profit margin of 4.7%, which is below the sector average, suggesting competitive pressure.
The company recently reported -0.2% revenue growth, which is negative, indicating a recent decline in revenue.
Return on Equity (ROE) is 4.2%, which suggests room for improvement in capital utilization.
At a current price of $6.13, OPRX currently trades near the bottom of its 52-week range (4%), indicating potential value or weakness (Range: $5.54 - $22.25).
💰 Valuation Insight
OPRX is valued broadly in line with the sector at a PE of 22.70. Analysts expect earnings growth, as indicated by a lower forward PE.